Latest News Archive
Please select Category, Year, and then Month to display items
12 June 2024
|
Story Lunga Luthuli
|
Photo supplied
![]()
Richard Molefe, a final-year BCom Investment Management and Banking
student at the University of the Free State (UFS), was recently elected uncontested as the National Chairperson of the Black Management Forum (BMF) National Student Chapter. The BMF aims to empower managerial leadership among black individuals in South Africa. Molefe's election signifies a step towards inclusive leadership structures that reflect wider societal values.
In an exclusive interview, Molefe shares his vision for youth empowerment and his plans for the Student Chapter's endeavours.
“The Black Management Forum’s programmes of development and advancement of managerial leadership and socio-economic transformation have exposed me to leadership opportunities that enhance my potential and aspirations. The opportunity is an indication that I have done something right, but I must constantly remind myself that I have not arrived,” said Molefe.
In his one-year term of office, Molefe wants to ensure that national structures of the Student Chapter exist and are functional, key pillars – promoting leadership, managerial leadership development skills, and entrepreneurial skills development in higher education institutions.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004